Company news
Nuvo Pharmaceuticals Inc news in 2020
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2020, newest first.
Miravo Healthcare(TM) Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets
December 21, 2020
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare(TM)
December 18, 2020
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
November 16, 2020
Nuvo Pharmaceuticals(TM) Announces Third Quarter 2020 Results Release Date and Conference Call Details
November 2, 2020
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th
October 5, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
September 14, 2020
Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx(TM) - For The Acute Treatment of Migraine
September 9, 2020
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results
August 10, 2020
Nuvo Pharmaceuticals(TM) Announces Second Quarter 2020 Results Release Date and Conference Call Details
July 27, 2020
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
May 12, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results
May 11, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders
April 27, 2020
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020
March 31, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
March 23, 2020
Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States
March 4, 2020
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine
February 27, 2020
Nuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results
February 25, 2020
Nuvo Pharmaceuticals(TM) Responds to Market Activity
February 11, 2020
Nuvo Pharmaceuticals(TM) Announces Fourth Quarter 2019 Results Release Date and Conference Call Details
February 11, 2020
Nuvo Pharmaceuticals(TM) Announces Repayment of Bridge Loan and Entitlement to Receive 2019 Vimovo U.S. Annual Minimum Royalty
January 7, 2020